Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · operational-macro

Canopy Growth Expands European Medical Cannabis Supply Into UK

22 September 2026 · By · Wire by Fusion42

Published

22 September 2026

Topic

operational-macro

◆ Sectors

Health

◆ Geography

United Kingdom

◆ Source

Read at cannabisbusinesstimes.com →

◆ Verified

Fusion42 · 23 September 2026 · Fusion42 review

Canopy Growth has announced the supply of four Canadian-grown medical cannabis flower strains to the U.K. market through Spectrum Therapeutics, expanding its European medical cannabis business. This expansion is supported by the EU GMP certification renewal at Canopy Growth's Ontario cultivation facility, enabling supply to European markets.

This Wire brief sits within Fusion42's coverage of Health.

◆ ◆ The Wire takeaway

You have a new market to challenge in the U.K. medical cannabis sector as Canopy Growth's certified supply unlocks European distribution channels. Expect pressure on pricing and compliance to win customers fast.

◆ Coverage

1 source · 22 Sep 2026

◆ Related on Wire

◆ Topics

Healthmedical-cannabismarket-entryeuropean-expansionhealthcaresupply-chain